Legal Representation
Attorney
Michelle Rosenberg
USPTO Deadlines
Next Deadline
140 days remaining
NOA E-Mailed - SOU Required
Due Date
December 24, 2025
Extension Available
Until June 24, 2026
Application History
14 eventsDate | Code | Type | Description | Documents |
---|---|---|---|---|
Jun 24, 2025 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
Apr 29, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
Apr 29, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
Apr 23, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
Apr 1, 2025 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
Mar 21, 2025 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
Mar 21, 2025 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
Mar 21, 2025 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Mar 8, 2025 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
Mar 8, 2025 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
Mar 8, 2025 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
Mar 5, 2025 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Aug 30, 2024 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
Aug 30, 2024 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
pharmaceutical preparations for lowering cholesterol; pharmaceuticals, namely, lipid lowering agents; pharmaceutical preparations for the prevention and treatment of cardiovascular diseases and disorders, major adverse cardiac events, cholesterol-related diseases and disorders, dyslipidemia, lipid-related diseases and disorders, diabetes, age-related macular degeneration, neurodegenerative diseases and disorders, dementia, Lewy body dementia, and Alzheimer's disease
Classification
International Classes
005